Skip to content

Johnson & Johnson Innovation - JJDC, Inc.

Follow

13F filer, CIK 924020, NEW BRUNSWICK, NJ

Johnson & Johnson Innovation - JJDC, Inc. filed a 13F-NT notice for the quarter ended 2026-09-30 on 2026-10-26.

Accepted , ingested 13F-NT 0000904454-26-000543

This filer reports no holdings of its own for Q3 2026. It filed a 13F-NT notice, and its holdings are in the report of . How notices are handled.

Changes against Q2 2026 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • CTNM CONTINEUM THERAPEUTICS INC: 13G/A 1,979,173 shares, 5.6% of the class, 13G/A filed 2026-11-06, 0000904454-26-000591Timeline
    Accepted , ingested
  • TRXB TREX BIO INC: 13G 1,475,302 shares, 5.3% of the class, 13G filed 2026-10-15, 0000904454-26-000517Timeline
    Accepted , ingested

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-NT 0000904454-26-000543 notice2026-10-26